Internal Medicine Journal

Cover image for Vol. 45 Issue 7

Edited By: Jeff Szer

Impact Factor: 1.644

ISI Journal Citation Reports © Ranking: 2014: 62/153 (Medicine General & Internal)

Online ISSN: 1445-5994

Recently Published Issues

See all

  • Current Issue:July 2015

    Volume 45, Issue 7

  • June 2015

    Volume 45, Issue 6

  • May 2015

    Volume 45, Issue 5

  • May 2015

    Volume 45, Issue Supplement S3

    Special Issue: Abstracts for RACP Congress 2015, B...

  • May 2015

    Volume 45, Issue Supplement S2

    Special Issue: Australian Rheumatology Association...

Top 5 Cited Papers - 2013 Impact Factor Period

Variability in vitamin D assays impairs clinical assessment of vitamin D status
J. K. C. Lai, R. M. Lucas, E. Banks, A.-L. Ponsonby and the Ausimmune Investigator Group

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies
G. Cheng, C. Huang, H. Deng and H. Wang

Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies
M. Dugar, S. Cox, V. Limaye, P. Blumbergs and P. J. Roberts-Thomson

Use of empiric antimicrobial therapy in neutropenic fever
C. S. Tam, M. O'Reilly, D. Andresen, S. Lingaratnam, A. Kelly, K. Burbury, J. Turnidge, M. A. Slavin, L. J. Worth, L. Dawson and K. A. Thursky

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication
D. Tong, N. Manolios, G. Howe and D. Spencer

Editor's Choice

Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management

K. Hull, I. Kerridge, S. Avery, M. McCullough, D. Ritchie and J. Szer

Data from the Australasian Bone Marrow Transplant Recipient Registry show a steady increase in the number of allogeneic haemopoietic stem cell transplantations (HSCT) performed annually in Australia and New Zealand. In 2012, 629 allogeneic HSCT were performed. Allogeneic HSCT is associated with numerous potential complications, including chronic graft-versus-host disease (cGVHD). This paper summarises the current status of allogeneic HSCT in Australia and New Zealand with a focus on oral cGvHD and the associated challenges in its management.